Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Proof of Concept (POC) in Patients With Ischaemic Stroke

This study has been terminated.
(This study was terminated for futility.)
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01808261
First received: February 14, 2013
Last updated: April 21, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2014
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: March 21, 2016